Yale-led research explains why many cancer drugs fail during clinical trial testing
Uncovering the mechanisms behind a mischaracterized drug could shed light on its poor performance in clinical trials, research suggests.
Source: yale.edu
Stay updated with breaking news from Sheltzer Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uncovering the mechanisms behind a mischaracterized drug could shed light on its poor performance in clinical trials, research suggests.